ARID4B and Parkinson disease: In this study, we measured plasma BCAA and AAA levels using high-performance liquid chromatography with fluorescence detection (HPLC-FLD) in a large cohort of 106 PD patients and 114 controls and found that plasma BCAAs and Tyr were decreased in PD patients.